Guided Dolorclast Therapy

What it is/ What it’s used for:

Musculoskeletal injuries can become chronic with the underlying condition worsening as the months pass by. If you have been feeling pain for more than 3 months, a combination of the DolorClast® High Power Laser and the DolorClast® Radial Shock Waves together with rehabilitation exercises are recommended to obtain long-term results.

Guided DolorClast® Therapy (GDT) is a new treatment concept based on combined therapies, dedicated to successfully, quickly and safely treat 90% of musculoskeletal disorders. 

Guided DolorClast® Therapy is best used for the treatment of:

• Tennis and Golfer’s elbow
  
• Rotator cuff tendinopathy 
  
• Upper back pain 
  
• Adhesive capsulitis 
  
• Lower back pain 
  
• Patella tip syndrome
  
• Knee osteoarthritis 
  
• Achilles tendinopathy 
  
• Plantar fasciitis 

How does Guided DolorClast® Therapy help in physical therapy? 

The DolorClast® High Power Laser provides a quick and strong analgesic effect without the need for conventional painkillers by providing: 

1. An analgesic effect: kicking in 5 min after the end of laser treatment and lasting up to 72h.
   
2. An anti-inflammatory effect: Decreasing acute inflammation and leading to a quick absorption of the oedema and a faster healing process of the damaged tissues. 

The DolorClast® Radial Shockwaves when applied to injured tissues, stimulate the following metabolic reactions

1. Reduction of pain felt by nerve fibres
   
2. Increase of blood circulation in surrounding soft tissues
   
3. Beginning of healing process triggered by stem cell activation
   

Using these 2 therapies together results in a decrease in acute inflammation which is as good as taking NSAIDS without the risks or side effects, combined with the benefits of Shock wave which include: 

1. an analgesic effect kicking in after the application of shock waves, coupled with a decrease of neurogenic inflammation.
   
2. New blood vessels formation (angiogenesis) in tissues, while blood circulation is stimulated, fostering fast healing of treated tissues. 
   
3. Increase of the formation of new cells for regeneration of the treated tissues without scar formation. 
   
4. Combining these therapies results in fast healing and return to motion. 

What does the Custom Guided DolorClast® Therapy (GDT) treatment process look like? 

Once it is established that GDT is a good treatment option for you, a baseline examination will be performed to quantify pain and movement before the first treatment session. These measurements will then be compared with your post-treatment measurements once your treatments are complete. 

You will receive 3 to 5 minutes of DolorClast® High Power Laser followed by a wait time of 5 min or 1 hour before starting your DolorClast® ShockWave therapy. 

Even though Guided DolorClast® Therapy (GDT)  works well as a stand alone treatment, We believe that combining DolorClast® High Power Laser and Shock Wave treatments with rehabilitation exercises improves clinical outcomes. Combining the two speeds up and increases overall functional recovery. 

STANDARD TREATMENT

• Treat with DolorClast® shock waves.

LATEST STATE-OF-THE-ART TREATMENT (SHORT SESSION: LASER + ESWT)

• Treat with DolorClast® laser for 3 min (GDT protocol), wait 5 min.,

then treat with DolorClast® shock waves.

LATEST STATE-OF-THE-ART TREATMENT (LONG SESSION: LASER + REHABILITATION + ESWT)

• Treat with DolorClast® laser for 3 min., (GDT protocol), wait 1 hour during which patient

can perform rehabilitation exercises, then treat with DolorClast® shock waves.

USE OF THE DOLORCLAST® HIGH POWER LASER

IS CONTRAINDICATED FOR:

• Treatment of areas affected by neoplasia.

• Treatment of pregnant women.

• Treatment over an implanted electrical stimulator.

(e.g. pacemaker)

DOLORCLAST® SHOCK WAVES

USE OF THE DOLORCLAST® RADIAL SHOCK WAVES

AND PIEZOCLAST® IS CONTRAINDICATED FOR:

• Treatment over air-filled tissue (lung, gut),

• Treatment of pre-ruptured tendons,

• Treatment of pregnant women,

• Treatment of patients under the age of 18

(except for the treatment of Osgood-Schlatter disease),

• Treatment of patients with blood-clotting disorders (including local thrombosis),

• Treatment of patients treated with oral anticoagulants,

• Treatment of tissues with local tumors or local bacterial and/or viral infections,

• Treatment of patients treated with cortisone.

(within the 6-week period following the last local cortisone injection)